RPS29P8

Across TCGA pan-cancer cohorts, RPS29P8 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RPS29P8 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RPS29P8 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPS29P8 expression acts as an unfavorable survival marker, although some lineages such as READ and SKCM show a favorable association.

READ, MESO, and THCA are the cancer types where RPS29P8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Median	All	0.735	0.354	<.001	73	view →
MESO	OS	Tertile	IV	0.307	0.668	.015	30	view →
THCA	DFS	Tertile	IV	0.572	1.000	<.001	25	view →
KIRC	OS	Tertile	II,III,IV	0.703	0.849	.018	24	view →
OV	OS	Tertile	II,III,IV	0.289	0.395	.023	16	view →
PRAD	DFS	Tertile	All	0.687	0.848	.012	10	view →
ESCA	OS	Quartile	All	0.392	0.627	.025	6	view →
SKCM	OS	Tertile	III,IV	0.596	0.337	.013	6	view →
COAD	DFS	Quartile	All	0.699	0.476	.029	4	view →
PAAD	OS	Median	III,IV	0.629	1.000	.022	3	view →
STAD	OS	Tertile	IV	0.494	0.111	.045	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RPS29P8–READ (DFS)

Open the READ breakdown →